Overexpression of gene CEP55 has been observed in variety of solid tumors, including colon cancer [26], bladder cancer [27], hepatocellular carcinoma [28], gastric cancer [29], esophagus adenocarcinoma [30] and ovarian carcinoma [24]. This evidence concerns the gene CEP55 and gastric cancer.